Chile and Brazil strengthen biotech and trade ties:
This article was originally published in Clinica
Executive Summary
Chile and Brazil have signed a series of bilateral accords in a range of areas including health technology and trade. Biotechnology and genomics are among the areas of common interest in medical research; the two countries plan to set up new projects in these areas. The Chilean and Brazilian presidents, Ricardo Lagos and Fernando Henrique Cardoso, met last week in Arica, northern Chile, to also sign commercial agreements that seek to improve the flow of trade between the two countries, such as by reducing import/export tariffs. Other technical co-operation agreements involve joint investments in Brazilian small and medium-sized companies, reports the state news agency Agencia Brasil.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.